Pagliarini David J, Wiley Sandra E, Kimple Michelle E, Dixon Jesse R, Kelly Patrick, Worby Carolyn A, Casey Patrick J, Dixon Jack E
Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
Mol Cell. 2005 Jul 22;19(2):197-207. doi: 10.1016/j.molcel.2005.06.008.
Reversible phosphorylation is the cell's most prevalent form of posttranslational modification, yet its role in the regulation of mitochondrial functions is poorly understood. We have discovered that a member of the dual-specific protein tyrosine phosphatase (DS-PTP) family, PTPMT1 (PTP localized to the Mitochondrion 1) resides nearly exclusively in mitochondria. PTPMT1 is targeted to the mitochondrion by an N-terminal signal sequence and is found anchored to the matrix face of the inner membrane. Knockdown of PTPMT1 expression in the pancreatic insulinoma cell line INS-1 832/13 alters the mitochondrial phosphoprotein profile and markedly enhances both ATP production and insulin secretion. These data define PTPMT1 as a potential drug target for the treatment of type II diabetes and strengthen the notion that mitochondria are an underappreciated site of signaling by reversible phosphorylation.
可逆磷酸化是细胞中最普遍的翻译后修饰形式,但其在线粒体功能调节中的作用却鲜为人知。我们发现,双特异性蛋白酪氨酸磷酸酶(DS-PTP)家族的一个成员PTPMT1(定位于线粒体的蛋白酪氨酸磷酸酶1)几乎只存在于线粒体中。PTPMT1通过N端信号序列靶向线粒体,并锚定在内膜的基质面上。在胰腺胰岛素瘤细胞系INS-1 832/13中敲低PTPMT1的表达会改变线粒体磷蛋白谱,并显著增强ATP生成和胰岛素分泌。这些数据将PTPMT1定义为治疗II型糖尿病的潜在药物靶点,并强化了线粒体是可逆磷酸化信号传导中一个未得到充分重视的位点这一观点。